Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

V. Koneti Rao, MD FRCPA, Elaine Kulm, Susan Price, Sharon Webster, BSN, Les Folio, MD, Gulbu Uzel, MD, David T Teachey, MD

Blood (2018) 132 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2018-99-117394

Published: 2018

Journal Articles

Utility of Fluorodeoxyglucose Positron Emission Tomography(FDG-PET) and Biomarkers, Serum Vitamin B12 and HDL for Assessing Lymphoproliferation in Children and Adults with Autoimmune Lymphoproliferative Syndrome Due to FAS Mutations (ALPS-FAS)

V. Koneti Rao, MD, Susan Price, Lori Dodd, Remaley Alan, Millie Whatley, Jorge Carrasquillo, MD, Clara C. Chen, MD

Blood (2016) 128 (22): 4891.

https://doi.org/10.1182/blood.V128.22.4891.4891

Published: 2016

Journal Articles

Clinical Spectrum of Autoimmune Lymphoproliferative Syndrome Associated with Caspase10 Mutations (ALPS-CASP10)

V. Koneti Rao, MD, Susan Price, Morgan Similuk, Julie Niemela, Joshua D Milner, MD, Sergio Rosenzweig, MD

Blood (2016) 128 (22): 1335.

https://doi.org/10.1182/blood.V128.22.1335.1335

Published: 2016

Journal Articles

Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations

Vollter Anastas, B.S., Weixin Wang, PhD, Susan Price, Zhen Zhao, PhD, V. Koneti Rao, MD, Katherine R. Calvo, MD PhD

Blood (2016) 128 (22): 4268.

https://doi.org/10.1182/blood.V128.22.4268.4268

Published: 2016

Journal Articles

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Katherine R. Calvo, Susan Price, Raul C. Braylan, Joao Bosco Oliveira, Michael Lenardo, Thomas A. Fleisher, V. Koneti Rao

Blood (2015) 125 (18): 2753–2758.

https://doi.org/10.1182/blood-2014-11-567917

Published: 2015

Includes: Supplemental data

Journal Articles

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Blood (2015) 125 (4): 591–599.

https://doi.org/10.1182/blood-2014-09-602763

Published: 2015

Includes: Supplemental data

Journal Articles

Elevated Interleukin-10 and “Disappearing HDL Syndrome” in Lymphoproliferative Disorders

Andreas Moriaitis, MD, Lita Freeman, PhD, Robert Shamburek, MD, Robert Wesley, PhD, Wyndham H. Wilson, MD PhD, Cliona Grant, MD, Susan Price, RN, Seth Thacker, PhD, Abdalrahman Zarzour, Frank Pucino, PharmD, Gyorgy Csako, Cheryl Yarboro, Iain McInnes, PhD, Takashi Kuroiwa, Dimitrios Boumpas, Gabor Illei, MD, Alan T. Remaley, V. Koneti Rao, MD

Blood (2014) 124 (21): 4134.

https://doi.org/10.1182/blood.V124.21.4134.4134

Published: 2014

Journal Articles

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

Susan Price, Pamela A. Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, Michael J. Lenardo

Blood (2014) 123 (13): 1989–1999.

https://doi.org/10.1182/blood-2013-10-535393

Published: 2014

Includes: Supplemental data

Journal Articles

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Katie Perkins, NP, Joie Davis, NP, Susan Price, RN, Julie Niemela, PhD, Andreas R. Huber, MD, Donna A. Wall, MD, Stefania Pittaluga, MD, PhD, Thomas A. Fleisher, MD, V. Koneti Rao, MD

Blood (2012) 120 (21): 2149.

https://doi.org/10.1182/blood.V120.21.2149.2149

Published: 2012

Journal Articles

Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML)

V. Koneti Rao, Joao Bosco Oliveira, MD, PhD, Julie Niemela, PhD, Joie Davis, NP, Susan Price, Hyesun Kuehn, Katherine R Calvo, MD, PhD, Stefania Pittaluga, Eric J. Werner, MD, Joohee Lee, MD, Mustafa Barbour, MD, Marc Natter, MD, Mignon L. Loh, MD, Thomas A Fleisher

Blood (2012) 120 (21): 1033.

https://doi.org/10.1182/blood.V120.21.1033.1033

Published: 2012

Journal Articles

Mycophenolate Mofetil and Thrombopoietin Receptor Agonists in the Treatment of Refractory Thrombocytopenia in Patients with Autoimmune Lymphoproliferative Syndrome

Leejah Chang, MD, Susan Price, RN, Katie Perkins, NP, Joie Davis, NP, Patricia Aldridge, CRN, Michael Recht, MD, PhD, John Kelleher, MD, V. Koneti Rao, MD

Blood (2011) 118 (21): 2218.

https://doi.org/10.1182/blood.V118.21.2218.2218

Published: 2011

Journal Articles

Causes and Consequences of Splenectomy In ALPS-FAS

Susan Price, Pamela Shaw, Jennifer Kirk, Joie Davis, Katie Perkins, Fred Gill, Thomas Fleisher, V. Koneti Rao

Blood (2010) 116 (21): 3908.

https://doi.org/10.1182/blood.V116.21.3908.3908

Published: 2010

Journal Articles

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Kennichi C. Dowdell, Julie E. Niemela, Susan Price, Joie Davis, Ronald L. Hornung, João Bosco Oliveira, Jennifer M. Puck, Elaine S. Jaffe, Stefania Pittaluga, Jeffrey I. Cohen, Thomas A. Fleisher, V. Koneti Rao

Blood (2010) 115 (25): 5164–5169.

https://doi.org/10.1182/blood-2010-01-263145

Published: 2010

Includes: Supplemental data

Journal Articles

Identifying Biomarkers in the Autoimmune Lymphoproliferative Syndrome (ALPS): IL-18, TNF-á, Serum Vitamin B12, Soluble FasL, and Plasma IL-10 Levels Are Useful Adjuvant Diagnostic Tools.

Iusta Caminha, Thomas Fleisher, Julie Niemela, Ron Hornung, PhD, Joie Davis, Katie Perkins, Kennichi Dowdell, PhD, Susan Price, RN, Margaret Brown, BSc, V. Koneti Rao, MD, FRCPA, Joao Bosco Oliveira, MD, PhD

Blood (2009) 114 (22): 1647.

https://doi.org/10.1182/blood.V114.22.1647.1647

Published: 2009

Journal Articles

Somatic Fas Mutations Account for Nearly One Third of Autoimmune Lymphoproliferative Syndrome (ALPS) Cases with Previously Unknown Genetic Mutations.

Kennichi Dowdell, PhD, Julie Niemela, Susan Price, Joie Davis, Katie Perkins, Janet Dale, Jennifer M. Puck, MD, Joao Bosco Oliveira, MD, PhD, Jeffrey Cohen, MD, Thomas Fleisher, MD, V. Koneti Rao, MD

Blood (2009) 114 (22): 710.

https://doi.org/10.1182/blood.V114.22.710.710

Published: 2009

Journal Articles

CT Scan Enumeration of Altered Spleen Status and Pulmonary Artery Size in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Elisabeth Wynne, Katie Perkins, Susan Price, RN, Adeline Louie, MD, V. Koneti Rao, MD, FRCPA

Blood (2009) 114 (22): 4034.

https://doi.org/10.1182/blood.V114.22.4034.4034

Published: 2009

Journal Articles

Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).

Janet K. Dale, RN, Susan Price, RN, Jean Tretler, RN, Patricia Aldridge, RN, Stephanie Montague, RN MSN, Joie Davis, APRN, Fred Gill, MD, Kip R. Hartman, MD, Linda C. Stork, MD, David J. Gnarra, MD, Lakshmanan Krishnamurti, MD, Jennifer Puck, MD, Thomas Fleisher, MD, V. Koneti Rao, MD

Blood (2007) 110 (11): 1319.

https://doi.org/10.1182/blood.V110.11.1319.1319

Published: 2007

Journal Articles

Adiponectin Produced by Lymphocytes Inhibits Granulopoiesis.

Lisa J. Crawford, PhD, Roy W. Peake, PhD, Susan Price, BSc, Treen C. Morris, MD, Alexandra E. Irvine, PhD

Blood (2006) 108 (11): 1275.

https://doi.org/10.1182/blood.V108.11.1275.1275

Published: 2006

Journal Articles

A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation

Lynn McCallum, Susan Price, Nathalie Planque, Bernard Perbal, Andrew Pierce, Anthony D. Whetton, Alexandra E. Irvine

Blood (2006) 108 (5): 1716–1723.

https://doi.org/10.1182/blood-2006-04-016113

Published: 2006

Journal Articles

BCR-ABL Decreases the Expression of CCN3 Leading to Increased Clonogenic Potential and Cell Growth.

Lynn M.R. McCallum, BSc PhD, Wanhua Lu, BSc MSc, Susan Price, BSc, Nathalie Planque, BSc PhD, Bernard Perbal, BSc PhD, Andrew Pierce, BSc PhD, Anthony Whetton, BSc PhD, Alexandra E. Irvine, BSc PhD

Blood (2005) 106 (11): 1216.

https://doi.org/10.1182/blood.V106.11.1216.1216

Published: 2005

NARROW

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

Utility of Fluorodeoxyglucose Positron Emission Tomography(FDG-PET) and Biomarkers, Serum Vitamin B12 and HDL for Assessing Lymphoproliferation in Children and Adults with Autoimmune Lymphoproliferative Syndrome Due to FAS Mutations (ALPS-FAS)

Clinical Spectrum of Autoimmune Lymphoproliferative Syndrome Associated with Caspase10 Mutations (ALPS-CASP10)

Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Elevated Interleukin-10 and “Disappearing HDL Syndrome” in Lymphoproliferative Disorders

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML)

Mycophenolate Mofetil and Thrombopoietin Receptor Agonists in the Treatment of Refractory Thrombocytopenia in Patients with Autoimmune Lymphoproliferative Syndrome

Causes and Consequences of Splenectomy In ALPS-FAS

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Identifying Biomarkers in the Autoimmune Lymphoproliferative Syndrome (ALPS): IL-18, TNF-á, Serum Vitamin B12, Soluble FasL, and Plasma IL-10 Levels Are Useful Adjuvant Diagnostic Tools.

Somatic Fas Mutations Account for Nearly One Third of Autoimmune Lymphoproliferative Syndrome (ALPS) Cases with Previously Unknown Genetic Mutations.

CT Scan Enumeration of Altered Spleen Status and Pulmonary Artery Size in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).

Adiponectin Produced by Lymphocytes Inhibits Granulopoiesis.

A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation

BCR-ABL Decreases the Expression of CCN3 Leading to Increased Clonogenic Potential and Cell Growth.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only